These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 10449309)

  • 1. Long-term antiretroviral combination therapy including lamivudine in HIV-1 infected women during pregnancy.
    Grubert TA; Wintergerst U; Lutz-Friedrich R; Belohradsky BH; Rolinski B
    AIDS; 1999 Jul; 13(11):1430-1. PubMed ID: 10449309
    [No Abstract]   [Full Text] [Related]  

  • 2. Dual therapy with lamivudine + protease inhibitor during pregnancy for prevention of mother-to-child transmission of HIV-1.
    Gliga SS; Clavel CO; Alix AF; Dommergues M; Quetin F; Marcelin AG; Schneider L; Stitou H; Calin R; Caby F; Valantin MA; Katlama C; Tubiana R
    J Acquir Immune Defic Syndr; 2013 Aug; 63(5):e159-63. PubMed ID: 24135778
    [No Abstract]   [Full Text] [Related]  

  • 3. Lactic acid levels in children perinatally treated with antiretroviral agents to prevent HIV transmission.
    Giaquinto C; De Romeo A; Giacomet V; Rampon O; Ruga E; Burlina A; De Rossi A; Sturkenboom M; D'Elia R
    AIDS; 2001 May; 15(8):1074-5. PubMed ID: 11399997
    [No Abstract]   [Full Text] [Related]  

  • 4. Combined stavudine and lamivudine during pregnancy.
    Ristola M; Salo E; Ammälä P; Suni J
    AIDS; 1999 Feb; 13(2):285. PubMed ID: 10202839
    [No Abstract]   [Full Text] [Related]  

  • 5. Evidence behind the WHO guidelines: hospital care for children: what antiretroviral agents and regimens are effective in the prevention of mother-to-child transmission of HIV?
    Nightingale S; Dabis F
    J Trop Pediatr; 2006 Aug; 52(4):235-8. PubMed ID: 16877674
    [No Abstract]   [Full Text] [Related]  

  • 6. Public Health Service Task Force recommendations for the use of antiretroviral drugs in pregnant women infected with HIV-1 for maternal health and for reducing perinatal HIV-1 transmission in the United States. Centers for Disease Control and Prevention.
    MMWR Recomm Rep; 1998 Jan; 47(RR-2):1-30. PubMed ID: 9461044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of mother-to-child HIV transmission using 3-drug combination antiretroviral treatment: observational cohort in clinical practice setting in India.
    Patel AK; Patel KK; Sharma R; Ranjan RR; Shukla RK; Patel JA
    J Acquir Immune Defic Syndr; 2009 Feb; 50(2):231-3. PubMed ID: 19155769
    [No Abstract]   [Full Text] [Related]  

  • 8. Antiretroviral therapy in the pregnant woman.
    Augenbraun M; Minkoff HL
    Obstet Gynecol Clin North Am; 1997 Dec; 24(4):833-54. PubMed ID: 9430170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. US Public Health Service Task Force recommendations for the use of antiretroviral drugs in pregnant women infected with HIV-1 for maternal health and for reducing perinatal HIV-1 transmission in the United States, February 25, 2000.
    United States Public Health Service Task Force. Perinatal HIV Guidelines Working Group
    HIV Clin Trials; 2000; 1(2):39-64. PubMed ID: 11590498
    [No Abstract]   [Full Text] [Related]  

  • 10. Persistence of genotypic resistance to nelfinavir among women exposed to prophylactic antiretroviral therapy during pregnancy.
    Kakehasi FM; Tupinambás U; Cleto S; Aleixo A; Lin E; Melo VH; Aguiar RA; Pinto JA
    AIDS Res Hum Retroviruses; 2007 Dec; 23(12):1515-20. PubMed ID: 18160009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multicenter randomized controlled trial of nevirapine versus a combination of zidovudine and lamivudine to reduce intrapartum and early postpartum mother-to-child transmission of human immunodeficiency virus type 1.
    Moodley D; Moodley J; Coovadia H; Gray G; McIntyre J; Hofmyer J; Nikodem C; Hall D; Gigliotti M; Robinson P; Boshoff L; Sullivan JL;
    J Infect Dis; 2003 Mar; 187(5):725-35. PubMed ID: 12599045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IAS position paper on prevention of HIV 1 mother-to-child transmission. International Aids Society.
    AIDS; 1999 Jul; 13(11):5-9. PubMed ID: 10449274
    [No Abstract]   [Full Text] [Related]  

  • 13. Antiretroviral therapies in pregnancy: maternal, fetal and neonatal effects. Swiss HIV Cohort Study, the Swiss Collaborative HIV and Pregnancy Study, and the Swiss Neonatal HIV Study.
    Lorenzi P; Spicher VM; Laubereau B; Hirschel B; Kind C; Rudin C; Irion O; Kaiser L
    AIDS; 1998 Dec; 12(18):F241-7. PubMed ID: 9875571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States (revised November 3, 2000).
    United States Public Health Service Task Force. Perinatal HIV Guidelines Working Group Members
    HIV Clin Trials; 2001; 2(1):56-91. PubMed ID: 11590515
    [No Abstract]   [Full Text] [Related]  

  • 15. Antiretroviral therapy during pregnancy. Beyond AZT (ZDV).
    Dattel BJ
    Obstet Gynecol Clin North Am; 1997 Sep; 24(3):645-57. PubMed ID: 9266584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Premature delivery in HIV-infected women starting protease inhibitor therapy during pregnancy: role of the ritonavir boost?
    Sibiude J; Warszawski J; Tubiana R; Dollfus C; Faye A; Rouzioux C; Teglas JP; Ekoukou D; Blanche S; Mandelbrot L
    Clin Infect Dis; 2012 May; 54(9):1348-60. PubMed ID: 22460969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiretroviral therapy during pregnancy and early neonatal life: consequences for HIV-exposed, uninfected children.
    El Beitune P; Duarte G; Quintana SM; Figueiró-Filho EA; Marcolin AC; Abduch R
    Braz J Infect Dis; 2004 Apr; 8(2):140-50. PubMed ID: 15361992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of saquinavir-SGC in HIV-infected pregnant women.
    Acosta EP; Zorrilla C; Van Dyke R; Bardeguez A; Smith E; Hughes M; Huang S; Pitt J; Watts H; Mofenson L;
    HIV Clin Trials; 2001; 2(6):460-5. PubMed ID: 11742433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiretroviral therapy in HIV-infected pregnant women and their infants: current interventions and challenges.
    Shannon M
    J Perinat Neonatal Nurs; 2002 Sep; 16(2):1-25. PubMed ID: 12233942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pregnancy danger.
    Posit Aware; 1998; 9(5):18. PubMed ID: 11365886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.